A second-generation CD38-CAR-T cell for the treatment of multiple myeloma.
Hongwen LiJing LiJiazhuo WuZhuangzhuang ShiYuyang GaoWenting SongJiwei LiZhaoming LiMing-Zhi ZhangPublished in: Cancer medicine (2023)
These results indicated a promising therapeutic strategy of CD38-CAR-T cells against MM.